NCT00371592View on ClinicalTrials.gov

Effectiveness of Acyclovir in Suppressing HIV Viral Load in Women Coinfected With HIV and Herpes Simplex Virus Type 2 (HSV-2)

PHASE2CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

September 30, 2006

Primary Completion Date

January 31, 2009

Study Completion Date

January 31, 2009

Conditions
HIV InfectionsHerpesvirus 2, Human
Interventions
DRUG

Acyclovir

800 mg tablet taken orally twice daily

DRUG

Acyclovir placebo

800 mg placebo tablet taken orally twice daily

Trial Locations (1)

32

IMPACTA - San Miguel CIPRA Project 1 CRS, San Miguel

All Listed Sponsors
collaborator

Comprehensive International Program of Research on AIDS

OTHER

lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00371592 - Effectiveness of Acyclovir in Suppressing HIV Viral Load in Women Coinfected With HIV and Herpes Simplex Virus Type 2 (HSV-2) | Biotech Hunter | Biotech Hunter